Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Variability in Modified Rankin Scoring Across a Large Cohort of International Observers
TL;DR: Interobserver variability in mRS assessment is confirmed, and the heterogeneity across countries is intriguing because it appears not to be related solely to language.
National Institutes of Health Stroke Scale Item Profiles as Predictor of Patient Outcome External Validation on Safe Implementation of Thrombolysis in Stroke–Monitoring Study Data
Azmil H. Abdul-Rahim,Rachael L. Fulton,Heidi Sucharew,Dawn Kleindorfer,Pooja Khatri,Joseph P. Broderick,Kennedy R. Lees +6 more
TL;DR: In this article, the authors used the latent class analysis probabilities of the profile membership generated from the derivation study onto NIHSS data from the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST).
Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy A Validation Study of Home Time as an Outcome Measure
Nishant K. Mishra,Ashfaq Shuaib,Patrick D. Lyden,Hans-Christoph Diener,James C. Grotta,Stephen M. Davis,Antoni Dávalos,Tim Ashwood,Warren W. Wasiewski,Kennedy R. Lees +9 more
TL;DR: HT is a responsive measure for use in multinational acute stroke trials and its inclusion as a complementary outcome is reasonable because it is an accessible and objective parameter free from subjective bias.
Long-Term Outcome following Attendance at a Transient Ischemic Attack Clinic:
Alan C. Cameron,Jesse Dawson,Terence J. Quinn,Matthew Walters,Gordon T. McInnes,David S. Morrison,William T. Sloan,Kennedy R. Lees +7 more
TL;DR: All patients attending transient ischemic attack clinics should undergo assessment of their cardiovascular risk and the use of methods to reduce this risk should be explored.
Termination of Acute Stroke Studies Involving Selfotel Treatment
TL;DR: Selfotel, a selective competitive N-methyl-D-aspartate antagonist, has neuroprotective efficacy in animal models of focal and global ischaemia and traumatic brain injury and the disappearance of salivary gland MALT lymphoma after Helicobacter pylori eradication is reported.